Cite

1. Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. The Lancet. 2013 Jun;381(9881):1943-55. DOI: 10.1016/S0140-6736(12)62187-410.1016/S0140-6736(12)62187-4Open DOISearch in Google Scholar

2. Bartram CR, Schrauder A, Köhler R, Schrappe M. Acute lymphoblastic leukemia in children: treatment planning via minimal residual disease assessment. Dtsch Arzteblatt Int. 2012 Oct;109(40):652-8.10.3238/arztebl.2012.0652Search in Google Scholar

3. Harrison CJ. Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia. Br J Haematol. 2009 Jan;144(2):147-56. DOI: 10.1111/j.1365-2141.2008.07417.x10.1111/j.1365-2141.2008.07417.xOpen DOISearch in Google Scholar

4. Pui C-H, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet Lond Engl. 2008 Mar 22;371(9617):1030-43. DOI: 10.1016/S0140-6736(08)60457-210.1016/S0140-6736(08)60457-2Open DOISearch in Google Scholar

5. Mullighan CG, Collins-Underwood JR, Phillips LAA, Loudin MG, Liu W, Zhang J, et al. Rearrangement of CRLF2 in B-progenitor and Down syndrome associated acute lymphoblastic leukemia. Nat Genet. 2009 Nov;41(11):1243-6. DOI: 10.1038/ng.46910.1038/ng.469278381019838194Open DOISearch in Google Scholar

6. Kamariah Ibrahim, Siti Sarah Daud, Yeow-Liang Seah, Allen E. Yeoh, Hany Ariffin. Rapid Detection of Prognostically Important Childhood Acute Lymphoblastic Leukemia Chimeric Transcripts Using Multiplex SYBR Green Real-Time Reverse Transcription PCR. Ann Clin Lab Sci. 2008;38(4):338-43.Search in Google Scholar

7. Harrison CJ. Acute lymphoblastic leukemia. Clin Lab Med. 2011 Dec;31(4):631-647, ix. DOI: 10.1016/j.cll.2011.08.01610.1016/j.cll.2011.08.01622118741Open DOISearch in Google Scholar

8. Brüggemann M, Schrauder A, Raff T, Pfeifer H, Dworzak M, Ottmann OG, et al. Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia. 2010 Mar;24(3):521-35. DOI: 10.1038/leu.2009.26810.1038/leu.2009.26820033054Search in Google Scholar

9. Ivanov IC, Jitaru D, Grigore GE, Zlei M, Ivanov A, Dumitraș S, et al. Infant acute leukemia with lineage switch at relapse expressing a novel t(4;11)(q21;q23) MLL-AF4 fusion transcript. Rev Romana Med Lab. 2013;21(1):47-58. DOI:10.2478/rrlm-2013-0017 DOI: 10.2478/rrlm-2013-001710.2478/rrlm-2013-0017DOI:10.2478/rrlm-2013-0017Open DOISearch in Google Scholar

10. Boldeanu FM, Gruia AT, Ordodi VL, Serban M, Bader P, Kreyenberg H. Childhood Acute Lymphoblastic Leukemia: Detection of Minimal Residual Disease after Allogeneic Transplantation. Rev Romana Med Lab. 2012;20(3):245-53Search in Google Scholar

11. Jardan D, Talmaci R, Jardan C, Coriu D, Colita A, Colita A, et al. Real-time qPCR for assessment of minimal residual disease in acute myeloid and lymphoid leukemia. Rev Romana Med Lab. 2011;19(4):349-57Search in Google Scholar

12. van der Does-van den Berg A, Bartram CR, Basso G, Benoit YC, Biondi A, Debatin KM, et al. Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the “BFM Family” Cooperative Group. Med Pediatr Oncol. 1992;20(6):497-505. DOI: 10.1002/mpo.295020060310.1002/mpo.29502006031435520Open DOISearch in Google Scholar

13. Gabert J, Beillard E, van der Velden VHJ, Bi W, Grimwade D, Pallisgaard N, et al. Standardization and quality control studies of “real-time” quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - A Europe Against Cancer Program. Leukemia. 2003 Dec;17(12):2318-57. DOI: 10.1038/sj.leu.240313510.1038/sj.leu.240313514562125Open DOISearch in Google Scholar

14. R Core Team. R: A Language and Environment for Statistical Computing [Internet]. R Foundation for Statistical Computing; 2014. Available from: http://www.R-project.orgSearch in Google Scholar

15. Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group. J Clin Oncol Off J Am Soc Clin Oncol. 2012 May 10;30(14):1663-9. DOI: 10.1200/JCO.2011.37.801810.1200/JCO.2011.37.8018Open DOISearch in Google Scholar

16. Bassan R, Hoelzer D. Modern therapy of acute lymphoblastic leukemia. J Clin Oncol Off J Am Soc Clin Oncol. 2011 Feb 10;29(5):532-43. DOI: 10.1200/JCO.2010.30.138210.1200/JCO.2010.30.1382Open DOISearch in Google Scholar

17. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012 Feb;62(1):10-29. DOI: 10.3322/caac.2013810.3322/caac.20138Open DOISearch in Google Scholar

18. Roganovic J. Acute Lymphoblastic Leukemia in Children. In: Guenova M, editor. Leukemia [Internet]. In- Tech; 2013 [cited 2017 Apr 19]. Available from: http://www.intechopen.com/books/leukemia/acute-lymphoblastic-leukemia-in-children10.5772/55655Search in Google Scholar

19. Lustosa de Sousa DW, de Almeida Ferreira FV, Cavalcante Félix FH, de Oliveira Lopes MV. Acute lymphoblastic leukemia in children and adolescents: prognostic factors and analysis of survival. Rev Bras Hematol E Hemoter. 2015 Jul; 37(4):223-9. DOI: 10.1016/j.bjhh.2015.03.00910.1016/j.bjhh.2015.03.009Open DOISearch in Google Scholar

20. Pui C-H, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009 Jun 25; 360(26):2730-41. DOI: 10.1056/NEJMoa090038610.1056/NEJMoa0900386Open DOISearch in Google Scholar

21. Gökbuget N, Kneba M, Raff T, Trautmann H, Bartram C-R, Arnold R, et al. Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies. Blood. 2012 Aug 30;120(9):1868-76.DOI: 10.1182/blood-2011-09-37771310.1182/blood-2011-09-377713Open DOISearch in Google Scholar

22. Liang D-C, Shih L-Y, Yang C-P, Hung I-J, Liu H-C, Jaing T-H, et al. Frequencies of ETV6-RUNX1 fusion and hyperdiploidy in pediatric acute lymphoblastic leukemia are lower in far east than west. Pediatr Blood Cancer. 2010 Sep;55(3):430-3. DOI: 10.1002/pbc.2262810.1002/pbc.22628Open DOISearch in Google Scholar

23. Weltgesundheitsorganisation, Swerdlow SH, International Agency for Research on Cancer, editors. WHO classification of tumours of haematopoietic and lymphoid tissues: [... reflects the views of a working group that convened for an Editorial and Consensus Conference at the International Agency for Research on Cancer (IARC), Lyon, October 25 - 27, 2007]. 4. ed. Lyon: Internat. Agency for Research on Cancer; 2008. 439 p. (World Health Organization classification of tumours).Search in Google Scholar

24. Maurer J, Janssen JW, Thiel E, van Denderen J, Ludwig WD, Aydemir U, et al. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet Lond Engl.1991 May 4;337(8749):1055-8. DOI: 10.1016/0140-6736(91)91706-Z10.1016/0140-6736(91)91706-ZSearch in Google Scholar

25. Sazawal S, Bhatia K, Gutierrez MI, Saxena R, Arya LS, Bhargava M. Paucity of TEL-AML 1 translocation, by multiplex RT-PCR, in B-lineage acute lymphoblastic leukemia (ALL) in Indian patients. Am J Hematol. 2004 May;76(1):80-2. DOI: 10.1002/ajh.2000010.1002/ajh.2000015114604Open DOISearch in Google Scholar

26. Oyekunle A, Haferlach T, Kröger N, Klyuchnikov E, Zander AR, Schnittger S, et al. Molecular Diagnostics, Targeted Therapy, and the Indication for Allogeneic Stem Cell Transplantation in Acute Lymphoblastic Leukemia. Adv Hematol. 2011;2011:1-8. DOI: 10.1155/2011/15474510.1155/2011/154745321628622110503Open DOISearch in Google Scholar

27. Diakos C, Xiao Y, Zheng S, Kager L, Dworzak M, Wiemels JL. Direct and indirect targets of the E2APBX1 leukemia-specific fusion protein. PloS One. 2014;9(2):e87602. DOI: 10.1371/journal.pone.008760210.1371/journal.pone.0087602391365524503810Search in Google Scholar

28. Hu Y, He H, Lu J, Wang Y, Xiao P, Li J, et al. E2APBX1 exhibited a promising prognosis in pediatric acute lymphoblastic leukemia treated with the CCLGALL2008 protocol. OncoTargets Ther. 2016 Nov;Volume 9:7219-25. DOI: 10.2147/OTT.S11525710.2147/OTT.S115257512580127920559Open DOISearch in Google Scholar

29. Vey N, Thomas X, Picard C, Kovascovicz T, Charin C, Cayuela JM, et al. Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/ E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study. Leukemia. 2006 Dec;20(12):2155-61. DOI: 10.1038/sj.leu.240442010.1038/sj.leu.240442017039234Open DOISearch in Google Scholar

30. Ballerini P, Landman-Parker J, Cayuela JM, Asnafi V, Labopin M, Gandemer V, et al. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE- 93: the effect of TLX3/HOX11L2 gene expression on outcome. Haematologica. 2008 Nov;93(11):1658-65. DOI: 10.3324/haematol.1329110.3324/haematol.1329118835836Open DOISearch in Google Scholar

31. Mansur MB, Emerenciano M, Brewer L, Sant’Ana M, Mendonça N, Thuler LCS, et al. SIL-TAL1 fusion gene negative impact in T-cell acute lymphoblastic leukemia outcome. Leuk Lymphoma. 2009 Aug;50(8):1318-25. DOI: 10.1080/1042819090304001410.1080/1042819090304001419562638Search in Google Scholar

32. D’Angio M, Valsecchi MG, Testi AM, Conter V, Nunes V, Parasole R, et al. Clinical features and outcome of SIL/TAL1-positive T-cell acute lymphoblastic leukemia in children and adolescents: a 10-year experience of the AIEOP group. Haematologica. 2015 Jan 1;100(1):e10-3.DOI: 10.3324/haematol.2014.11215110.3324/haematol.2014.112151428132725304610Search in Google Scholar

33. Matutes E, Pickl WF, van’t Veer M, Morilla R, Swansbury J, Strobl H et al. Mixed- phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification. Blood. 2011;117:3163-71 DOI: 10.1182/ blood-2010-10-31468210.1182/blood-2010-10-31468221228332Open DOISearch in Google Scholar

eISSN:
2284-5623
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Life Sciences, Molecular Biology, Biochemistry, Human Biology, Microbiology and Virology